Repligen Corporation
RGEN
$147.06
$6.054.29%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 5.08% | -1.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.08% | -1.85% | |||
| Cost of Revenue | 9.45% | -8.62% | |||
| Gross Profit | 1.62% | 4.29% | |||
| SG&A Expenses | 0.11% | 2.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.61% | -2.53% | |||
| Operating Income | 9.90% | 5.76% | |||
| Income Before Tax | 698.70% | -90.73% | |||
| Income Tax Expenses | 239.38% | -212.62% | |||
| Earnings from Continuing Operations | -39.90% | -37.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -39.90% | -37.28% | |||
| EBIT | 9.90% | 5.76% | |||
| EBITDA | 2.73% | 2.07% | |||
| EPS Basic | -39.96% | -37.33% | |||
| Normalized Basic EPS | 12.81% | -4.10% | |||
| EPS Diluted | -39.96% | -35.72% | |||
| Normalized Diluted EPS | 13.05% | -4.07% | |||
| Average Basic Shares Outstanding | 0.11% | 0.08% | |||
| Average Diluted Shares Outstanding | -0.05% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||